ERG protein expression as a biomarker of prostate cancer

Author： Falzarano Sara Moscovita Magi-Galluzzi Cristina

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.6, 2013-12, pp. : 851-865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy

THE PROSTATE, Vol. 75, Iss. 14, 2015-10 ,pp. : 1499-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

THE PROSTATE, Vol. 75, Iss. 11, 2015-08 ,pp. : 1216-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

EN2: a novel prostate cancer biomarker

By McGrath Sophie E Michael Agnieszka Morgan Richard Pandha Hardev

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 893-901

Future Medicine

Access to resources Recommend Favorite

Expression of Stanniocalcin 1 as a Potential Biomarker of Gastric Cancer

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 158-164

Karger

Access to resources Recommend Favorite